Highlight
injury-induced infection is confirmed affected by the sympathetic/parasympathetic nervous system, hypothalamic-pituitary-adrenal axis, and even brain-gut axis. In this review, we summarized the mechanisms of CNS injury-induced infection, crosstalk between the CNS and the immune system and current pharmacological intervention to provide ideas for the development of new anti-infective therapeutic strategies.
Introduction
Studies have found that the patients with acute central nervous system (CNS) injury (such as traumatic brain injury, spinal cord injury and stroke (ischemic, hemorrhagic)) have a high incidence of systemic infections, especially pneumonia and urinary tract infections. These infections have received increasing attention for it might affect the recovery of neurological function and increase the rate of morbidity and mortality, which pose great challenge to the patients (Hazeldine et al., 2015; Kopp et al., 2017; Kwan et al., 2013) . The total infection rate of stroke-associated infections (pneumonia and urinary tract infections) is about 30% (Westendorp et al., 2011) , and the incidence of early onset pneumonia after traumatic brain injury is about 40% (Bronchard et al., 2004) . In addition, the infection (pneumonia or postoperative wound infection) rate of acute traumatic spinal cord injury (pneumonia or postoperative wound infection) was up to 47%, of which pneumonia accounts for a considerable proportion . After CNS injury, many factors contribute to pulmonary infection, such as age, J o u r n a l P r e -p r o o f severity of injury, dysphagia, nasal feeding, mechanical ventilation and aspiration , invasive surgery, immunosuppression caused by CNS injury (Hoffmann et al., 2017; Winklewski et al., 2014; Wong et al., 2017) , and intestinal flora translocation (Stanley et al., 2016) . Clinical studies have shown that stroke-associated infections, especially pneumonia, had a greater impact on the prognosis of stroke patients within three years, increased 30 days, 1 year (Ingeman et al., 2011; Katzan et al., 2003) and 3 years mortality . Moreover, pneumonia may be associated with a higher risk of stroke recurrence (Erdur et al., 2015) .Therefore the effective control of infection, especially lung infection, is of great significance in improving the prognosis, survival rate and quality of life of patients with CNS injury.
Antibiotics are commonly used in the treatment of various infections. The standard treatment for patients with CNS injury diagnosed as infection also is prompt use of antibiotics. However, the alarming increase of antibiotic resistant strains and potential adverse effects must be considered (Winek et al., 2016) . Noradrenergic overactivation and excess glucocorticoid release were thought to be the reason of CNS injury caused immunosuppression, thus researches exploring the potential of adrenergic receptor blockers and glucocorticoid receptor antagonist to reduce CNS injury-associated infection have been conducted. However, the results were controversial, some demonstrated it works, others found no effect or even increased infection rates (Maier et al., 2015; Prüss et al., 2017; Starr et al., 2017) . CNS injury may disrupt multiple biological processes that ultimately increase susceptibility to infections, thus the treatment target only a single biological process is improbable.
J o u r n a l P r e -p r o o f
What could be efficacious in inhibiting the prevalent and grave consequence of infection in CNS injury? In this review, we discuss the reasons and biological mechanisms underlying vulnerability to infections in the population with CNS injury, and the current and potential avenues, that will be helpful to design tailored treatment strategies, so as to improve the prognosis of patients with CNS injury.
Intestinal bacterial translocation mediated infection after CNS injury
In current clinical studies, CNS injury patients often lead to gut microbiota dysbiosis, gut dysmotility, gastrointestinal bleeding, and even gut-origin sepsis, which is often associated with worsen outcomes, including deteriorating functional deficits and increased mortality rates (Camara-Lemarroy et al., 2014; Chou et al., 2017; Yamashiro et al., 2017; Zhang et al., 2018) . In turn, imbalanced intestinal microbiota is known to affect the recovery of neurological function and neuropathology (Berer et al., 2011; Ma et al., 2017; Mayer et al., 2015; Singh et al., 2016 (Kigerl et al., 2016) . Similarly, J o u r n a l P r e -p r o o f experimental stroke also causes microbiota dysbiosis, which in turn affects stroke outcome. Interestingly, transplantation of fecal microbiota could improve stroke prognosis and normalize brain lesion induced dysbiosis (Singh et al., 2016) .
The gut, a complex organ, not only be responsible for nutrient absorption, but also acts as a barrier to prevent harmful substances (such as bacteria and toxins) invading into other tissues or blood. Therefore, strictly regulated control of gut integrity is particularly important for host antibacterial immune defense, as gut microbes may exit the gastrointestinal tract and translocation into other tissues in many critical diseases (Balzan et al., 2007; Kigerl et al., 2016; Stanley et al., 2018) .
Some studies have shown that the translocation of intestinal bacteria was the main source of infection in the lung, urinary tract and other infections after severe CNS injury (Stanley et al., 2016; Stanley et al., 2018) .
Recent studies have shown that intestinal microbial translocation from the host gut to surrounding tissues plays a key role in the development of infection after stroke.
In a small group of infected stroke patients, more than 70% of the culturable bacteria in their blood, sputum and urine were intestinal commensal bacteria, including Enterococcus spp., Escherichia coli and Morganella morganii. A similar phenomena was observed in animal models, 24 hours after middle cerebral artery occlusion (MCAO) onset, bacterial biomass in ileum and colon decreased significantly, while significantly increased in lung, and about 60% of the bacterial communities in the lungs were derived from small intestine. Further studies showed that intestinal microflora translocation was associated with impaired intestinal mucosal barrier J o u r n a l P r e -p r o o f function, gut and vascular permeability were increased, the distribution of tight junctional protein ZO-1 was altered, and goblet cell numbers in the jejunum and ileum were increased (Stanley et al., 2016) . 
CNS injury induced immunodeficiency and infection
Inflammation after infection is affected by both the nervous system and the immune system through some factors, and the central nervous system plays a major role among the nervous system. CNS interacts with the immune system in complex bi-directional way. Inflammatory cells activate and infiltrate into the part tissue after CNS injury. Although after CNS injury the inflammatory reaction contributes to remove tissue fragmentation and repair damaged tissues, intracerebral inflammation can expand the injury lesions and aggravate neurological function impairment in the acute stage of CNS injury. (Fu et al., 2015; Urday et al., 2015) . In other words, inflammatory reactions after stroke promote tissue healing and eliminate necrotic cells, whereas excessive inflammatory reactions may cause secondary damage. Immune tissues and immune cells can automatically regulate the excessive immune inflammation caused by CNS injury, and the nervous system also plays a regulatory role in the anti-inflammatory response. Neurological regulatory anti-inflammatory J o u r n a l P r e -p r o o f effect is beneficial in the presence of systemic inflammation, which is conducive to wound healing, elimination of necrotic cells, and prevention of excessive inflammatory response and severe immunosuppression. However, the clinical and experimental researches have reported that in the absence of systemic inflammation, the anti-inflammatory response triggered by local inflammatory cytokine diffusion may be harmful after CNS injury, because it can down regulation the body's defensive capacity and make the body susceptible to infection Meisel et al., 2005) . Moreover, other clinical studies have found that patients with CNS injury showed impaired immune function (Catania et al., 2009; Meisel et al., 2005; Wong et al., 2017) . The main clinical features include rapid and sustained decline of cellular immune function, inactivation of monocytes and type 1 helper T cells (Type 1 t-helper cells, Th1), Th-mediated lymphocyte reduction (Haeusler et al., 2008) , spleen, thymus and lymph node atrophy et al (Prüss et al., 2017; Zhang et al., 2018) . Therefore, the complex mechanism of infection after CNS injury may be closely related to sympathetic nervous system, parasympathetic nervous system and HPA axis.
Sympathetic nervous system (SNS) mediated immunodeficiency
Except for conventional functions, the SNS is responsible for the protection of body against injury and foreign antigens and pathogens, including modulation of inflammation and the immune system. Effector molecules of the SNS can work upon adrenergic receptors on immune cells. Activation of SNS results in the release of catecholamines (CAs), which includes epinephrine, norepinephrine and dopamine (Bellinger and Lorton, 2014; Felten et al., 1987; Liu et al., 2018) . Overwhelming J o u r n a l P r e -p r o o f evidence indicated that the β-adrenergic signal have important immunological effects (Goyarts et al., 2008; Panina-Bordignon et al., 1997; Sanders et al., 1997; Woiciechowsky et al., 1998) . intensive care management and hospitalization time . Meanwhile, Sykora et al reported a non-randomized study include 5212 patients with ischemic stroke, which indicated that the use of β-blockers before or after stroke was associated with a reduction in the incidence of pneumonia, and the use of β-blockers during stroke was associated with reduced mortality (Sykora et al., 2015) . However, another study involving 625 patients reported that the use of β-blockers before stroke and continued use during hospitalization did not reduce the risk of stroke-related pneumonia, only reduce the incidence of urinary tract infections. In addition, patients treated with β-blockers had a higher 30-day mortality rate than those not exposed to β-blockers (Maier et al., 2015) . Therefore, the safety of β-adrenergic receptor blockers in the treatment of CNS damage-related infections is still controversial, so it needs to be used cautiously. In general, cholinergic anti-inflammatory pathway mainly include vagus nerve, spleen and α7 nicotinic acetylcholine receptor (α7nAChR) (Duris et al., 2017) . Bernik et al found that vagotomy can inhibit cholinergic signaling and then inhibit TNF-α synthesis (Bernik et al., 2002) . At present, many laboratories achieve neuroinhibition of inflammation by activating cholinergic anti-inflammatory pathway. This method has been used in the treatment of inflammatory bowel disease, rheumatoid arthritis, ischemia-reperfusion injury and postoperative ileitis et al model (Reardon, 2016; Shi et al., 2018) . J o u r n a l P r e -p r o o f effect for experimental stroke (Chi et al., 2018) . Therefore, the therapy targeting cholinergic anti-inflammatory pathway can be used as a new method to prevent and treat neuroinflammation. However, it is worth noting, that over-stimulation of cholinergic pathways after CNS injury may aggravate the risk of infection .
Parasympathetic nervous system (PNS)-mediated immunodeficiency

HPA axis-mediated immunodeficiency
In general, the activity of the HPA axis is regulated by multiple afferent (Liberman et al., 2018; Meagher et al., 1996; Ronchetti et al., 2018; Wilckens and De Rijk, 1997) .
The GC produced by HPA axis is related to the immunosuppression after CNS injury, which may alters hematopoietic output of the bone marrow. Findings from several animals' studies suggest that post-ischemic stroke lymphocyte production reduced is mediated by the HPA axis, and stroke-induced GC release as the main instigator of B lymphopoiesis defects (Courties et al., 2019; Mracsko et al., 2014) . In mice with Angiostrongylus cantonensis infection, the infection can enhanced endogenous corticosteroid activity, resulting in peripheral immunosuppression, sharp decrease of splenic and thymic cells. The reporter believed that this was due to B cell genesis cessation and impairing thymocyte development , and the therapy of given glucocorticoid receptor antagonists could partially restore the infectioninduced cessation of B cell genesis .
Interaction of SNS, PNS and HPA axis in CNS injury induced immunodeficiency and infection
Many complex diseases are usually not caused by changes in a single pathway but by an unbalanced regulating network resulting from the dysfunctions of multiple pathways. A large number of studies have shown that the immune suppression after CNS injury is not caused by single sympathetic nerve, parasympathetic nerve or HPA axis, but may be caused by the imbalance between several systems results. At the same time a research shown that activation of adrenergic and HPA axis pathway induced peripheral splenic atrophy and NK cell deficiency through the synergistic J o u r n a l P r e -p r o o f effect of norepinephrine and GC after acute ischemic brain injury, while the lack of NK cells in the brain was mediated by cholinergic innervation (Liu et al., 2017) . In the middle cerebral artery occlusion model, observed that the use of propranolol and mifepristone to inhibit the SNS and HPA axis, inhibit the body's main stress reaction axis and thus block the immunosuppression caused by stroke, which could significantly reduce the infarction volume and infection rate of mice, and improve the long-term survival rate (Romer et al., 2015) . In addition, the classical concept adrenal glands to restore physiological GC levels, it can completely protect animals from pneumonia infection (Prüss et al., 2017) . This suggests that over-regulation of a certain mechanism may not effectively prevent infection. Regulation of the balance J o u r n a l P r e -p r o o f between SNS, PNS and HPA axis may be an effective strategy to prevent anti-infection.
Pharmacological intervention of the CNS injury induced infection
Antibiotics are usually used for treatment of infection. To improve CNS injury patient outcome, there have been attempts to lessen the associated infection through prophylactic use of antibiotics. Vermeij noted that preventive antibiotic therapy in the acute phase of stroke reduces the overall infection rate, it does not improve functional prognosis or reduce mortality. Therefore, preventive antibiotic therapy is effective only for stroke patients in specific subgroups (Vermeij et al., 2018) . In some clinical studies have shown that prophylactic antibiotics administration in acute stroke patients did not significantly prevent pneumonia, shorten length of hospital stay or reduce in-hospital or follow-up mortality. Taken together, prophylactic antibiotics therapy is not recommended for acute stroke patients (Kalra et al., 2015; Westendorp et al., 2015) . With the increasing number of problems facing antibiotic treatment, there is an urgent need for new ways to reduce stroke-related infections. β-Blockers selectively adrenergic receptors union, inhibiting downstream CNS activation, thereby reducing the probability of immunosuppressive response after stroke and decrease infection (Wong et al., 2011) . Subsequently, based on the mechanism of immune suppression caused by over-activation of SNS, the clinical use of β-blockers to block nerve function to prevent infection. And the effects of selective and non-selective β-blockers on infection are different, non-selective blockers may even increase the risk of infection (Maier et al., 2015; Maier et al., 2018; Starr et al., 2017) , and further J o u r n a l P r e -p r o o f study selective blockers that can avoid adverse reactions. However, the safety of β-blockers remains controversial, that may due to its adverse effects on heart rate, vascular tension, cerebral blood supply and other factors. One reason for the β-blockers cannot prevent post-stroke immunodepression may be the cardioselective (β-1 receptor selective) β-blockers. Based on the above ideas, the treatment effect of immune suppression and infection after CNS injury is not ideal, so some researchers made futher study immune suppression comprehensively from HPA axis. In regard to the HPA axis is still in the pre-clinical stage of study, some researchers reported that the post-stroke immunodepression is result from neurohormonal dysregulation of the SNS and HPA-axis. In a mouse model, use pharmacological blockade the body's stress axes to inhibite stroke-induced immunodepression (SIDS) increase antigen-specific T-cellresponses inthe brain (Romer et al., 2015) . In an animals study the glucocorticoid receptor (GCR) stimulation induces lymphocytopenia, and catecholamines probably cause impaired lymphocytic IFN-c secretion after extensive stroke. Use GCR inhibition can abrogate post-stroke lymphocytopenia caused by elevated GC level, β2-AR can alter lymphocyte IFN-γ secretion. Consequently, such as blocking the GC receptor use RU486, which can prevent the immune cell depletion (lymphocyte reduction, etc.) after CNS injury, but some studies have shown that it is not ideal for the prevention of pneumonia (Mracsko et al., 2014; Prüss et al., 2017; Romer et al., 2015) , or to inhibit the cholinergic anti-inflammatory pathway. In recently years, owing to gut microbiota research gained much attention in medical research, more and more studies focus on bacterial translocation. So improving J o u r n a l P r e -p r o o f intestinal bacterial translocation by targeting intestinal tight junctions to regulate intestinal barrier function may be a new treatment regimen for preventing infection after CNS injury (Stanley et al., 2016) .
But the clinical cure rate of above methods is not very high. The most direct treatment should be to enhance the immune function of patients with CNS injury, such as the use of cytokines to promote the recovery of specific lymphocyte populations inhibited by CNS injury, but this method has not been tried in animal models and patients. More importantly, immunomodulation therapy seems to be beneficial for patients with CNS injury, but the effect is limited. The severity of CNS injury has a risk of aggravating brain inflammation and hindering the recovery of nerves. It is also critical to judge the time of inflammation and anti-inflammatory reaction in the brain after CNS injury (Fu et al., 2015; Prass et al., 2003) . In the clinical studies the patient should be administered immune modulators early in ICH, as longterm use may exacerbate immune suppression (Zhang et al., 2018) . Intriguingly, immunomodulatory therapies have focused on reduce certain immune cells and inflammatory mediators damage on the extent of tissue damage in the post-stroke infection. And the risks of immune modulation in the acute phase of stroke are limited. But the immunomodulatory therapies mechism and therapy time is not explicitness, therefor the further preclinical and clinical work research is needed (Veltkamp and Gill, 2016) .
Therefore, immune intervention must strike a balance between preventing immune-mediated damage and allowing inflammation to promote nerve repair.
Conclusions
In summary, CNS injury affects a variety of biological processes, such as the SNS, PNS, HPA axis and brain-gut axis, resulting in the disturbance of normal and balanced interaction between immune system and CNS, which ultimately increases the susceptibility to infection (Fig. 1) . Prevention of infection is a potential method to ameliorate long-term prognosis for the patients with CNS injury. Present therapeutics that specifically target individual ways of CNS injury associated infection include:
prophylactic use of antibiotics, regulate SNS/HPA axis, immunomodulatory therapy, and new way to prevent dissemination of gut bacteria by protecting the intestinal barrier integrity. We note that with the increasing of antibiotic resistant strains, pharmacologic modulation of neurogenic innervations may provide an option to improve immune defenses against post-CNS injury infection, however, it is important to ensure whether enhancing immunity will aggravate brain damage (Revathikumar et al., 2016; Shim and Wong, 2018) . Current treatment regimens mostly targeted at a single mechanism, and the effect of improving the infection and long-term prognosis after CNS injury is not ideal. Therefore, a comprehensive approach for prevention and management of infection is required. Based on the complicated mechanism of CNS injury-associated infection, multi-pathway and multi-target regulation may be a potential development direction to combat CNS injury-related infections. For example, regulating the balance between the SNS, PNS and HPA axis to enhance the immunity without affecting the recovery of neurological function, and meanwhile, the integrity of the intestinal barrier is repaired and the bacterial translocation is blocked. In this article we elaborate the multifaceted biological mechanisms that involved in infection caused by CNS injury, in order to provide us new ideas to develop powerful and targeted treatment regimens to significantly improve survival rate, long-term neurological function, and patient outcomes. 
